Evidence map›Paper›PMID 31826941›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

T Cells Produce IFN-α in the TREX1 D18N Model of Lupus-like Autoimmunity.

Sean R Simpson, Stephen L Rego, Scott E Harvey, Mingyong Liu, Wayne O Hemphill, Rajkumar Venkatadri, Rahul Sharma, Jason M Grayson, Fred W Perrino

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Mouse models of type I interferonopathies.Human molecular genetics · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. International journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. TREX1 as a Novel Immunotherapeutic Target.Frontiers in immunology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sean R SimpsonDepartment of Biochemistry, Center for Structural Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157.
Stephen L RegoDepartment of Biochemistry, Center for Structural Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157.ORCID 0000-0002-8389-9706
Scott E HarveyDepartment of Biochemistry, Center for Structural Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157.
Mingyong LiuDepartment of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC 27157; and.
Wayne O HemphillDepartment of Biochemistry, Center for Structural Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157.
Rajkumar VenkatadriCenter for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908.ORCID 0000-0003-3632-865X
Rahul SharmaCenter for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908.
Jason M GraysonDepartment of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC 27157; and.
Fred W PerrinoDepartment of Biochemistry, Center for Structural Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157; fperrino@wakehealth.edu.
Wake Forest University · USCenter for Neuroscience and Regenerative Medicine · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
TRAINING PROGRAM IN IMMUNOLOGY AND PATHOGENESIST32AI007401 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Martha Ann Alexander-Miller · 1991 to 2026
$4.4M
The TREX1 Pathway in Autoimmune DiseaseR01AI116725 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PERRINO, FRED W · 2016 to 2020
$1.9M
Regulatory T Cells in Acute Kidney InjuryR01DK104963 · NIDDK · UNIVERSITY OF VIRGINIA · PI SHARMA, RAHUL · 2016 to 2020
$1.8M
Structural and Computational Biophysics Training ProgramT32GM095440 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOLLIS, THOMAS J, LYLES, DOUGLAS S. · 2011 to 2020
$1.7M
Targeting Treg for Therapy of Lupus GlomerulonephritisR01DK105833 · NIDDK · UNIVERSITY OF VIRGINIA · PI FU, SHU MAN, SHARMA, RAHUL · 2016 to 2019
$1.4M
Circulating Renal-Protective Mediators in Cardiac Surgery PatientsR21DK112105 · NIDDK · UNIVERSITY OF VIRGINIA · PI LYNCH, KEVIN R., ROSNER, MITCHELL H. · 2017 to 2018
$443k
NCI NIH HHS P30 CA012197NIAID NIH HHS R01 AI116725NIAID NIH HHS T32 AI007401NIDDK NIH HHS R01 DK104963NIDDK NIH HHS R01 DK105833NIDDK NIH HHS R21 DK112105NIGMS NIH HHS T32 GM095440
6 · The paper itself

Abstract

Autoimmunity can result when cells fail to properly dispose of DNA. Mutations in the three-prime repair exonuclease 1 (TREX1) cause a spectrum of human autoimmune diseases resembling systemic lupus erythematosus. The cytosolic dsDNA sensor, cyclic GMP-AMP synthase (cGAS), and the stimulator of IFN genes (STING) are required for pathogenesis, but specific cells in which DNA sensing and subsequent type I IFN (IFN-I) production occur remain elusive. In this study, we demonstrate that TREX1 D18N catalytic deficiency causes dysregulated IFN-I signaling and autoimmunity in mice. Moreover, we show that bone marrow-derived cells drive this process. We identify both innate immune and, surprisingly, activated T cells as sources of pathological IFN-α production. These findings demonstrate that TREX1 enzymatic activity is crucial to prevent inappropriate DNA sensing and IFN-I production in immune cells, including normally low-level IFN-α-producing cells. These results expand our understanding of DNA sensing and innate immunity in T cells and may have relevance to the pathogenesis of human disease caused by TREX1 mutation.

Indexed as

AnimalsAutoantigensAutoimmunityCells, CulturedCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDisease Models, AnimalDNAExodeoxyribonucleasesHumansImmunity, InnateInterferon-alphaLupus Erythematosus, SystemicMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutAutoantigenscGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNAExodeoxyribonucleasesInterferon-alphaMembrane ProteinsNucleotidyltransferasesPhosphoproteinsSting1 protein, mouseSTING Proteinthree prime repair exonuclease 1

Identifiers

PMID31826941
PMCPMC6946867
OpenAlexW2995122702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.